GENE ONLINE|News &
Opinion
Blog

2017-12-31|

December 31, 2015: Researchers First Used CRISPR to Treat a Genetic Disease in Mice

by GeneOnline
Share To

Researchers at the Duke University used CRISPR technology to treat Duchenne Muscular Dystrophy (DMD), and published the report on December 31, 2015 on Science journal. DMD is a genetic disease that can also occur in humans. This was the first case in which CRISPR technology is used to treat inherited diseases in adult mammals and was of great importance to the development of human gene therapy.

Reference
http://www.sciencemag.org/news/2015/12/crispr-helps-heal-mice-muscular-dystrophy

©www.geneonline.com All rights reserved. Collaborate with us: service@geneonlineasia.com
Related Post
The U.S. FDA Grants Orphan Drug Designation to NS-089/NCNP-02 for the Treatment of DMD
2023-08-17
Sanofi Inks Two Major Strategic R&D Collaborations in a Single Week
2023-07-24
M&A
Sherlock Biosciences Buys Sense Biodetection to Accelerate CRISPR-Based Handheld Diagnostic Tests
2023-02-02
LATEST
BIODND – An AI-Powered Database That Breaks New Ground in Life Science Business Development
2023-11-29
GeneOnline’s Weekly News Highlights: Nov 20-Nov 24
2023-11-27
SK Bioscience and Hilleman Laboratories Join Forces for Ebola Vaccine Development
2023-11-23
BeiGene to Expand Oncology Pipeline Through ENSEM Therapeutics Partnership
2023-11-23
Advancing the Frontiers of Cell and Gene Therapy – An Interview with Dr. Shin Kawamata
2023-11-21
Astellas and Pfizer’s Drug Receives FDA Approval as Treatment for High-Risk Prostate Cancer Recurrence
2023-11-21
GeneOnline’s Weekly News Highlights: Nov 13-Nov 17
2023-11-20
EVENT
2023-11-30
2023 Healthcare+ EXPO・Taiwan
Taipei , Taiwan
Scroll to Top